Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry

Recruiting now

Conditions studied: Stress Urinary Incontinence, Pelvic Organ Prolapse

In brief

The objective of this post market, clinical registry is to evaluate the performance of the products of the TVT family of products or vaginal vault or uterine prolapse repair (with laparotomic or laparoscopic approach including robotic assisted) using either Gynemesh PS Mesh or Artisyn Mesh in women undergoing surgery for SUI and POP.

Key facts

Study ID

NCT04829175

Run by

Ethicon, Inc.

People needed

1000

Starts

2022-04-11

Expected to finish

2038-03-31

Last updated by the study team

2026-07-06

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patients who satisfy all of the following criteria will be considered eligible for enrollment in this registry:
• SUI
• Stress urinary incontinence symptoms
• Urodynamic stress incontinence confirmed with urodynamic testing
• Female patient ≥ 21 years of age
• Desired surgical correction of SUI using synthetic pubo-urethral vaginal sling
• Planned surgery for primary SUI
• Patient able and willing to participate in follow-up
• Patient or authorized representative has signed the approved Informed consent POP
• Uterine or vaginal vault prolapse symptoms 2. Urodynamic testing (optional) 3. Female patient ≥ 21 years of age 4. Desired surgical correction of POP using synthetic mesh 5. Planned surgery for uterine or vaginal vault prolapse with or without concomitant SUI surgery 6. Patient able and willing to participate in follow-up 7. Patient or authorized representative has signed the approved Informed consent

You may not qualify if…

• Patients meeting any of the following criteria will be considered not eligible for enrollment in this registry:
• Physical or psychological condition which would impair registry participation or are unwilling or unable to participate in all required registry visits and are unable to complete the questionnaires
• Any pre-operative or intra-operative findings identified by the surgeon that may preclude the use of registry products
• History of previous synthetic, biologic or fascial sub-urethral sling (SUI) or pelvic mesh (POP)
• Pregnancy or plans for future pregnancy
• History of bleeding diathesis or current anti-coagulation therapy which cannot be suspended peri-operatively according to site's standard practice
• Current genitourinary fistula or urethral diverticulum
• Reversible cause of incontinence (i.e. drug effect) for SUI only
• Severe vaginal atrophy
• History of pelvic irradiation therapy
• Contraindication to surgery

Where it is running

• Yale University — New Haven, Connecticut, United States (enrolling)
• Duke University — Durham, North Carolina, United States (enrolling)
• University of Pennsylvania — Philadelphia, Pennsylvania, United States (enrolling)
• UPMC — Pittsburgh, Pennsylvania, United States (enrolling)
• Krankenhaus der barmherzigen Schwestern — Linz, Austria (enrolling)
• Bio-Medical University Rome — Rome, Italy (enrolling)
• Karolinska Institute — Stockholm, Sweden (enrolling)
• Universitatsklinikum Tubingen — Tübingen, Germany
• Herlev Hospital — Hillerød, Denmark
• Hopital Jeanne de Flandres — Lille, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.